About
General Information
Program Agenda
Registration
Hotel & Travel
Press
iStock-623519652

The American Headache Society (AHS) is a professional society of healthcare providers dedicated to the study and treatment of headache and face pain. The Society’s objectives are to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals and the public and encouraging scientific research are the primary functions of this organization. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, publication of the journal Headache and sponsorship of the American Migraine Foundation.

Book Now
iStock-623519652

SCIENTIFIC PROGRAM COMMITTEE
Chair
Peter J. Goadsby, MD, PhD, FAHS
University of California San Francisco
San Francisco, CA

Members

Jessica Ailani, MD, FAHS
Medstar Georgetown University Hospital
Washington, DC

Amy Gelfand, MD, FAHS
University of California San Francisco
San Francisco, CA

Rami Burstein, PhD
Harvard Medical School
Waltham, MA

Ana Recober, MD, FAHS
Children’s Hospital of Philadelphia
Philadelphia, PA

Dawn C. Buse, PhD, FAHS
Albert Einstein College of Medicine
Bronx, NY

Ann I. Scher, PhD, FAHS
Uniformed Services University of the Health Sciences
Bethesda, MD

Andrew C. Charles, MD, FAHS
University of California Los Angeles
Los Angeles, CA

Todd J. Schwedt, MD, MSCI, FAHS
Mayo Clinic Arizona
Phoenix, AZ

Amaal Starling, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ

ABOUT THE AMERICAN HEADACHE SOCIETY®
The American Headache Society® (AHS) is a professional society of healthcare providers dedicated to the study and treatment of headache and face pain. The Society’s objectives are to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals and the public, and encouraging scientific research are the primary functions of this organization. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, publication of the journal Headache.

WHO SHOULD ATTEND?

The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

AHS has dedicated over 60 years to leading and serving the headache community.

THE AMERICAN HEADACHE SOCIETY’S® ANNUAL SCIENTIFIC MEETING continues to be the premiere venue for the dissemination of the latest and most up-to-date research and scientific advances underlying the practice of Headache Medicine.

EDUCATIONAL OBJECTIVES

At the conclusion of this meeting, attendees should be better able to:

  • Explain the biology underlying the fluctuating clinical features of migraine.
  • Identify the science around common clinical issues in headache
  • Recognize emerging therapeutic strategies for the treatment of headache disorders.

EDUCATION MISSION STATEMENT

The provision of quality CME is a primary mission of the American Headache Society® The Society’s educational objectives are to continue to improve the knowledge, skills, and professional performance of physicians, psychologists, and other health professionals in the care of patients with head, neck, and orofacial pain by:

  • Providing a forum for presentation of free scientific communication on research and clinical practice
  • Providing educational symposia
  • Improving education in medical schools and residency programs
  • Identifying and developing new educational initiatives
  • Supporting educational programs directed to people with head, neck, and orofacial pain
  • Maintaining strict adherence to ACCME guidelines

Developing education activities and tools that are designed and then evaluated for their role in improving the learners’ competence, performance, and the overall quality and safety of the care they give to individuals suffering from head, neck, and orofacial pain.

CONTINUING MEDICAL EDUCATION
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. The American Headache Society® takes responsibility for the content, quality, and scientific integrity of this CME activity.

The American Headache Society® designates AMA PRA Category 1 credit(s)™ for the medical education activity, the 60th Annual Scientific Meeting, for a maximum of 23.25 credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENT
All contributors who can affect American Headache Society CME content (including Leadership, Program Chairs, Moderators, Faculty Members, Medical Writers and Staff), in their respective roles, are required to disclose all relevant financial relationships with any commercial interest that could be viewed as a real or perceived conflict of interest. Contributors will also identify relevant financial relationships of their spouse. This policy is in effect to maintain adherence with the conflict of interest guidelines set by the Accreditation Council for Continuing Medical Education (ACCME) and the American Headache Society Ethics Committee.

Attendees will be made aware of any affiliation or relevant financial interest that may affect the development, management, presentation or evaluation of the CME activity and will be printed in the final program and projected in slide format before each presentation. Individuals who refuse to disclose relevant financial relationships will be disqualified from being a contributor, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity.

SPECIAL NOTE FOR THE PHYSICALLY CHALLENGED
The American Headache Society® wishes to take steps to ensure that no individual with disability is excluded, denied services, segregated, or otherwise treated differently than other individuals because of the absence of auxiliary aids and services. If you need any auxiliary aids or services identified in the Americans with Disabilities Act, or any assistance in registering for this symposium, please contact AHS Meeting Manager, Amy Valentin at 856-423-0043, write to her at AHS, 19 Mantua Road, Mt. Royal, NJ, 08061, or email AHSHQ@talley.com.

Book Now
iStock-623519652

AHS 2018 Annual Scientific Meeting
Program Agenda*
*Agenda subject to change

Please click here for a downloadable Program Agenda.

WEDNESDAY, JUNE 27, 2018

1:00 pm – 5:00 pm – Women’s Leadership Development Course
Moderators: Rebecca Burch, MD, FAHS, Rashmi B. Halker, MD, FAHS and Rebecca E. Wells, MD, FAHS

1:00 pm – 1:50 pm – Sponsorship versus Mentorship: Tools for Advancing Your Career and Helping Others Around You
Elizabeth L. Travis, PhD

1:50 pm – 2:00 pm – Q&A

2:00 pm – 2:50 pm – Negotiation for Women; Tips on Leadership Roles, Contracts, Salaries, etc.; Experience & Perspective from a Female Neurology Chair
Allison Brashear, MD

2:50 pm – 3:00 pm – Q&A

3:00 pm – 4:30 pm – Panel Discussion: My Career in Medicine and How I Make It Work
Moderator: Barbara Hoese
Panelists: Sheena Aurora, MD, FAHS; Allison Brashear, MD; Denise Chou, MD; Kathleen Digre, MD, FAHS; Judy Lane, MD; Elizabeth Loder, MD, MPH, FAHS; Claudia Lucchinetti, MD

4:30 pm – 5:00 pm – Our Calling Cards: A Reflection on Goals and Values
Barbara Hoese

THURSDAY, JUNE 28, 2018

8:00 am – 10:30 am – Pre-meeting Courses

8:00 am – 10:30 am – Course I: Innovations and Lessons Learned from Current Behavioral Headache Research
Presented by the Behavioral Issues Section and Methodology, Design and Statistical Issues Sections

8:00 am – 8:30 am – New Evidence in Medication Overuse Headache
Frank Andrasik, PhD

8:30 am – 9:00 am  – Clinical Trials in Pediatric Headache Medicine
Scott Powers, PhD

9:00 am – 10:00 am – Mindfulness for Migraine: Recent Clinical Trial Evidence
Elizabeth K. Seng, PhD

10:00 am – 10:30 am – Discussion
Donald B. Penzien, PhD

8:00 am – 10:30 am – Course II: Navigating Integrative Medicine Approaches with Patients Based on Evidence
Presented by Complementary and Integrative Medicine Section

8:00 am – 8:35 am – Case Presentation
Deena Kuruvilla, MD

8:35 am – 9:25 am – Acupuncture
Adelene Jann, MD

9:25 am – 10:10 am         Mindfulness and Meditation
Rebecca Erwin Wells, MD, MPH, FAHS

10:10 am – 10:25 am – Conclusion
Deena Kuruvilla, MD

8:00 am – 10:30 am – Course III: A Practical Approach to Procedures in Headache Medicine: A Review of Current Evidence and Cases in Clinical Practice
Presented by Procedures in Headache Medicine Section

8:00 am – 8:10 am – Introduction
Jessica Ailani, MD, FAHS

8:10 am – 8:40 am – Anatomy and Mechanisms of Procedures
Carrie Beth Robertson, MD, FAHs

8:40 am – 9:00 am – Evidence for Procedures
Matthew S. Robbins, MD, FAHS

9:00 am – 9:30 am – Performing Procedures in the Clinic
Andrew Blumenfeld, MD

9:30 am – 9:50 am – Procedures in Special Populations (Pediatrics, Pregnancy, Geriatrics) with Cases
Christina L. Szperka, MD

9:50 am – 10:15 am – Case-based Billing and Coding
Jessica Ailani, MD, FAHS

10:15 am – 10:30 am – Q & A
All Faculty

8:00 am – 10:30 am – Course IV: UCNS Review Course

8:00 am – 8:05 am – Introduction to UCNS
Noah Rosen, MD, FAHS

8:05 am – 8:25 am – Introduction to ICHD3
Morris Levin, MD, FAHS

8:25 am – 8:45 am – Secondary Headaches
Noah Rosen, MD, FAHS

8:45 am – 9:05 am – TACs
Rashmi B. Halker, MD, FAHS

9:05 am – 9:30 am – Headache Epidemiology, Pathophysiology & Genetics
Andrew C. Charles, MD, FAHS

9:30 am – 9:50 am – Migraine Treatment
Jessica Ailani, MD, FAHS

9:50 am – 10:10 am – Headache in Special Populations: Children/Adolescents, Pregnancy/Lactation and the Elderly
Lauren Doyle Strauss, DO

10:10 am – 10:25 am – High Yield Images
Stephanie Nahas, MD, FAHS

10:25 am – 10:30 am – Q & A

10:30 am – 12:30 pm – Pan-American /Asian Symposium

Moderators: Fabiola Dach, MD, PhD and Toshi Shimizu, MD, PhD

10:30 am – 10:45 am -Prediction of Migraine Attack by Resting EEG
Dr. Kuan-Lin Lai

10:45 am – 10:50 am – Discussion

10:50 am – 11:05 am – Headache and Migraine in Parkinson’s Disease
Dr. Keisuke Suzuki

11:05 am – 11:10 am – Discussion

11:10 am – 11:25 am – Short Sleep Duration and Poor Sleep Quality Among Migraineurs
Dr. Tae-Jin Song

11:25 am – 11:30 am – Discussion

11:30 am – 11:45 am – Cognitive Impairment of Patients with Chronic Migraine Does Not Depend on the Use of Topiramate or Comorbidities
Dr. Karen dos Santos Ferreira

11:45 am – 11:50 am – Discussion

11:50 am – 12:05 am – Allodynia in Menstrually Related Migraine
Dr. Eliana Meire Melhado

12:05 pm – 12:10 pm – Discussion

12:10 pm – 12:25 pm – Clomiphene Treatment May Be Effective in Refractory Episodic and Chronic Cluster Headache
Dr. Maria Eduarda Nobre

12:25 pm – 12:30 pm – Discussion and Closing Remarks

12:30 pm – 2:00 pm – Industry-supported Event

12:30 pm – 2:00 pm – Industry-supported Event
Satellite Symposium: Managing Patients in Urgent Need of Preventive Migraine Care: When Prophylactic Needs Shouldn’t Wait
Supported by Alder BioPharmaceuticals, Inc. Session is not certified for CME credits.

1:00 pm – 2:00 pm – Industry-supported Event
Product Theater: gammaCore® (nVNS) Scientific and Clinical Basis for the Acute Treatment of Headache
Supported by electroCore, LLC. Session is not certified for CME credits.

2:15 pm – 2:45 pm  – Welcome / Opening Remarks / AMF Update

2:45 pm – 4:30 pm – Symposium in Honor of Neil H. Raskin, MD, FAHS
Moderator: R. Allan Purdy, MD, FAHS and Joel R. Saper, MD, FAHS

2:45 pm – 3:00 pm – Welcome / Dr. Raskin Comments                     

3:00 pm – 3:30 pm – Channelopathies
Louis Ptacek, MD

3:30 pm – 4:00 pm – Clinical Contributions of Neil H. Raskin
Peter J. Goadsby, MD, PhD, FAHS

4:00 pm – 4:30 pm – UCSF – The Next Generation
Amy Gelfand, MD, FAHS

4:30 pm – 5:15 pm – AHS Membership Meeting

5:15 pm – 6:30 pm – Exhibit and Poster Reception

6:30 pm – 8:00 pm – Industry-supported Event
Satellite Symposium: Patient Perspectives and Future Therapeutics on Preventive Therapies for Migraine
Supported by Eli Lilly and Company.

7:00 – 8:00 pm – Industry-supported Event
Product Theater: e-TNS for the Treatment of Migraine
Support by Cefaly Technology. Session not certified for CME credits.

8:00 pm – 9:00 pm – Committee and Section Meetings

FRIDAY, JUNE 29, 2018

6:30 am – 8:00 am – Committee and Section Meetings

6:30 am – 8:00 am – Academic Program Director Meeting (invitation only)

6:30 am – 8:00 am – Continental Breakfast

6:30 am – 8:00 am – Exhibits and Posters
(Exhibit area closed 11:30 am – 1:15 pm)

8:00 am – 8:45 am – Seymour Solomon Award Lecture
Under Pressure
Recipient: Deborah I. Friedman, MD, MPH, FAHS

8:45 am – 9:00 am – Lifetime Achievement Award
Presented by Kathleen B. Digre, MD, FAHS
Recipient: Robert B. Daroff, MD, FAHS

9:00 am – 9:15 am – NIH Roadmap for Migraine Research
Michael Oshinsky, PhD

9:15 am – 9:30 am – 3rd Annual Migraine Moment Short Film Contest Winner Viewing

9:30 am – 10:45 am – Future of Headache Medicine
Includes IHA Presentations and NIT Submissions
Moderator: Werner Becker, MD, FAHS and Matthew S. Robbins, MD, FAHS

9:30 am – 9:40 am – IHA Research Grant Presentation
Incidence, Consequences and Prevention of Postoperative, Pain-related Hospital Readmission in Migraineurs
Katharina Platzbecker, MD

9:40am – 9:50 am – IHA Research Grant Presentation
Photosensitivity, Tactile Hypersensitivity and Pain-related Facial Features as Objective Biomarkers of Chronic PTH
Anne-Sophie Wattiez, PhD

9:50am – 10:00 am – New Investigator Presentation
FHM01
Disruptions of Awake Glutamate Signaling in Two Models of Migraine
Patrick Parker, BSc

10:00 am – 10:10 am – New Investigator Presentation
FHM02
Effects of Subthreshold Single Pulse Transcranial Magnetic Stimulation (sTMS) on Cortical Excitability Relevant to Migraine
Anna P. Andreou, PhD

10:10 am – 10:20 am – New Investigator Presentation
FHM03
Symptoms of Autonomic Dysfunction in Persistent Post-Traumatic Headache Versus Migraine
Levi Howard, MD

10:20 am – 10:30 am – New Investigator Presentation
FHM04
Profiling Corticotropin-Releasing Factor Receptor Pharmacology and Signaling in Transfected Cells and the Trigeminal Ganglia
Zoe Tasma, BSc

10:30 am – 10:40 am – New Investigator Presentation
FHM05
Investigating Cellular and Synaptic Mechanisms Underlying Migraine Phenotype in the Casein Kinase 1 Delta (CK1δ) Mutant Mouse
Pratyush Suryavanashi, MS

10:45 am – 11:30 am – Committee and Section Meetings

10:45 am – 11:30 am – Refreshment Break in Exhibit and Poster Hall

11:30 am – 1:00 pm – Scientific Paper Presentations – Session 1
Includes Frontiers in Headache Research Scholarship Presentations
Moderators: Rashmi Halker, MD, FAHS and Stewart J. Tepper, MD, FAHS

11:30 am – 11:40 am – LBOR-01
Differences in fibertract profiles between patients with migraine and those with persistent post-traumatic headache
Catherine Chong, MD

11:40 am – 11:50 am – OR-02
Assessing Unmet Treatment Needs and Associated Disability in Persons with Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study
Richard B. Lipton, MD

11:50 am – 12:00 pm – OR-03
Lasmiditan Inhibits CGRP Release in the Mouse Trigeminovascular System
Antoinette Maassen van den Brink, PhD

12:00 pm – 12:10 pm – LBOR-02
Enrichment of migraine susceptibility genes in the enteric nervous system
William Renthal, MD

12:10 pm – 12:20 pm – OR-05
Neuroinflammatory Marker Expression in Cerebral Cortex After Non-invasive Optogenetic Induction of Spreading Depolarization in Mice
Tsubasa Takizawa, MD, PhD

12:20 pm – 12:30 pm – OR-06
Life with Migraine, Effect on Relationships: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Dawn C. Buse, PhD, FAHS

12:30 pm – 12:40 pm – OR-07
When Mom Has Migraine: An Observational Study of the Burden of Parental Migraine on Children
Elizabeth K. Seng, PhD, FAHS

12:40 pm – 12:50 pm – OR-08
Profiling Antagonist Pharmacology at CGRP (CLR/RAMP1) and AMY1 (CTR/RAMP1) Receptors
Debbie Hay, PhD

12:50 pm – 1:00 pm – Frontiers in Headache Research Scholarship Presentation
Differential Regulation of Migraine-associated Pain and Negative Affect by Central and Peripheral Delta Opioid Receptors
Isaac Dripps, PhD

1:00 pm – 1:15 pm – Scholarship Award Presentation
Presented by Andrew C. Charles, MD, FAHS

1:15 pm – 2:15 pm – Lunch for Purchase in Exhibit and Poster Hall (authors present)

1:15 pm – 2:15 pm – Electronic Poster Presentations
Moderators: Jessica Ailani, MD, FAHS; Morris Levin, MD, FAHS; Amynah Pradhan, PhD and Bert Vargas, MD, FAHS

2:15 pm – 3:00 pm – Harold G. Wolff Award Lecture (OR 17)
Moderator: Andrew C. Charles, MD, FAHS
Identifying Natural Subgroups of Migraine based on Profiles of Comorbidities and Concomitant Conditions: Results of the Chronic Migraine Epidemiology and Outcomes Study 
Richard B. Lipton, MD

3:00 pm – 4:00 pm – PLENARY-Part 1
Science Behind Common Clinical Issues
Moderators: Rami Burstein, PhD and Todd Schwedt, MD, FAHS

3:00 pm – 3:20 pm – Migraine and Epilepsy
Eric Kossoff, MD

3:20 pm – 3:40 pm – Epidemiology of Incidental Findings
Randolph W. Evans, MD, FAHS

3:40 pm – 4:00 pm – Evidence Basis Behind the Use of Supplements
Tamara Pringsheim, MD

4:00 pm – 5:00 pm – PLENARY – Part 2
Therapeutic Targets of the Future
Moderators: Rami Burstein, PhD and Todd Schwedt, MD, FAHS

4:00 pm – 4:20 pm – Role of the Hypothalamus in Primary Headache Disorders
Andrew C. Charles, MD, FAHS

4:20 pm – 4:40 pm – The Cycling Brain
Catherine Chong, PhD

4:40 pm – 5:00 pm – Peripheral Nervous System Targets
Chelsea Hesterman, MD 

5:00 pm – 6:30pm – Industry-supported Event
Satellite Symposium: New Era of Migraine Management: The Changing Landscape in Prevention
Supported by Teva

5:30 pm – 6:30pm – Industry-supported Event
Product Theater: A New Therapy for Your Patients
Supported by Amgen, Inc./Novartis Pharmaceuticals. Session not certified for CME credits.

SATURDAY, JUNE 30, 2018

7:00am – 8:00 am – Industry-supported Event
Product Theater: Introducing Pulsante (SPG Stimulation) a New Treatment for Chronic Cluster
Supported by Autonomic Technologies, Inc. Session not certified for CME credits.

6:30 am – 8:00 am – Continental Breakfast

6:30 am – 2:15 pm – Exhibits and Posters
(Exhibit hall closed 10:30 am – 12:00 pm)

8:00 am – 10:00 am – Industry-submitted Abstracts*
*Session not eligible for CME
Moderators: Andrew C. Charles, MD, FAHS and Elizabeth W. Loder, MD, MPH, FAHS

8:00 am – 8:10am – IOR-01
Long-term Safety and Tolerability of Erenumab: Three-plus Year Results from an Ongoing Open-label Extension Study in Episodic Migraine
Messoud Ashina, MD, PhD, DMSc

8:10 am – 8:20 am  – IOR-02
Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan Compared to Placebo for Acute Treatment of Migraine
Linda A. Wietecha, BSN, MS

8:20 am – 8:30 am – IOR-03
Eptinezumab Reduced Migraine Activity and Achieved High Migraine Responder Rates over Weeks 1‒12: Results from the Phase 3 PROMISE-2 Trial in Chronic Migraine
Paul K. Winner, DO, FAHS

8:30 am – 8:40 am – IOR-04
Eptinezumab Achieved Meaningful Reductions in Migraine Activity as Early as Day 1:PROMISE-2 (Prevention of Migraine via Intravenous Eptinezumab Safety and Efficacy-2) Phase 3 Trial in Chronic Migraine
David Kudrow, MD

8:40 am – 8:50 am – IOR-05
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Post-hoc Analyses of Two Phase 3 Studies
Sheena K. Aurora, MD

8:50 am – 9:00 am – IOR-06
A Multicenter, Prospective, Randomized, Open-Label Study to Compare OnabotulinumtoxinA and Topiramate for headache Prevention in Adults with Chronic Migraine: Patient Reported Outcomes from the FORWARD study
Andrew Blumenfeld, MD

9:00 am – 9:10 am – IOR-07
The Impact of Fremanezumab on Medication Overuse in Patients with Chronic Migraine
Stephen D. Silberstein, MD, FAHS

9:10 am – 9:20 am – IOR-08
Efficacy and Safety of Erenumab in Episodic Migraine Patients with 2–4 Prior Preventive Treatment Failures: Results from the Phase 3b LIBERTY Study
Peter J. Goadsby, MD, PhD

9:20 am – 9:30 am – IOR-09
Assessment of Pharmacokinetics, Target Engagement and Immunogenicity in Patients with Migraine Administered Galcanezumab, an Anti-CGRP Antibody
William Kielbasa, PhD

9:30 am – 9:40 am – IOR-10
Low-Dose (3 Mg) Sumatriptan Injection (DFN-11) Efficacy, Tolerability, and Safety in Episodic Migraine: RESTOR, a Randomized, Double-Blind, Placebo Controlled Study
Stephen Landy, MD

9:40 am – 9:50 am – IOR-11
Achievement of Response with Fremanezumab in the Treatment of Chronic Migraine
Paul K. Winner, DO, FAHS

9:50 am – 10:00 am – IOR-01LB
Ubrogepant for the Acute Treatment of Migraine: Efficacy, Safety, Tolerability, and Functional Impact Outcomes from a Single Attack Phase III Study, ACHIEVE I
David W. Dodick, MD, FAHS

10:00 am – 10:10 am – IOR-02LB
Efficacy, Safety, and Tolerability of Rimegepant 75 mg, an Oral CGRP Receptor Antagonist, for the Acute Treatment of Migraine: Results from a Double-Blind, Randomized, Placebo-Controlled Trial, Study 302
Richard B. Lipton, MD

10:10 am – 10:20 am – IOR-03LB
Study CGAL: A Phase 3 Placebo-Controlled Study of Galcanezumab in Patients with Episodic Cluster Headache: Results from the 8-Week Double-Blind Treatment Phase
Sheena K. Aurora, MD, FAHS

10:00 am – 10:30 am – Refreshment Break in Exhibit and Poster Hall

10:30 am – 12:00 pm – Scientific Paper Presentations Including Late Breaking Abstract Presentations and Frontiers in Headache Research Scholarship Presentations Session 2
Moderators: Deborah I. Friedman, MD, MPH, FAHS and Robert Shapiro, MD, PhD

10:30 am – 10:40 am – OR-09
Peripheral CGRP-induced Spontaneous Pain in a Pre-clinical Mouse Model of Migraine
Levi Sowers, PhD

10:40 am – 10:50 am – OR-10
Accuracy of Appraisal of Headache Trigger Patterns Using Calendars
Dana P. Turner, MSPH, PhD

10:50 am – 11:00 am – OR-11
Triptan Use and Discontinuation in a Representative Sample of Persons with Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study
Aftab Alam, MBBS, MS, MBA

11:00 am – 11:10 am – OR-12
Non-invasive Stimulation of the Vagal Nerve Reduces Provoked Cranial Autonomic Output in Healthy Volunteers
Maike Moeller, M.Sc.

11:10 am – 11:20 am – OR-13
Profiling Calcitonin Gene-related Peptide Receptor Signaling in Transfected Cells and Trigeminal Ganglia Neurons
Christopher S. Walker, PhD

11:20 am – 11:30 am – OR-14
Post-Traumatic vs Non-Traumatic Headaches: A Phenotypic Analysis
Andrea Metti, PhD

11:30 am – 11:40 am – LBOR-03
Age-related Cortical Thickness Changes in Chronic Migraine
Yohannes W. Woldeamanuel, MD

11:40 am – 11:50 am – LBOR-04
Adverse childhood experience and medication overuse headache: frequency and effects on response to treatment
Claire H. Sandoe, MD, MSc

11:50 am – 12:00 pm –  Frontiers in Headache Research Scholarship Presentation
Photoreceptor-specific Mechanisms of Migraine-associated Photophobia
Eric Kaiser, MD, PhD

12:00 pm – 1:00 pm – DEBATE
Migraine Triggers Should Always be Avoided
Moderator: Dawn C. Buse, PhD, FAHS
PRO – Richard B. Lipton, MD, FAHS
CON – Paul R Martin, OAM, FBPsS, Hon FAPS

1:00 pm – 2:15 pm – Lunch for Purchase in Exhibit and Poster Hall (authors present)

2:15 pm – 3:45 pm – Scientific Paper Presentations – Session 3
Moderators: Kathleen B. Digre, MD, FAHS and Robert E. Shapiro, MD, PhD

2:15 pm – 2:25 pm – OR-15
Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
Rashmi B. Halker, MD, FAHS

2:25 pm – 2:35 pm – OR-16
Migraine Pattern Changes in Women During the Menopause Transition
Yu-Chen Cheng, MD, MPH

2:35 pm – 2:45 pm – LBOR-05
Examination of the psychometric properties of the Headache Specific Locus of Control Scale in People with Migraine
Dawn C. Buse, PhD

2:45 pm – 2:55 pm – LBOR-06
Interest and Demand for Non-Opioid, Non-Drug Treatment Options for Migraine
Rebecca E. Wells, MD, MPH, FAHS

2:55 pm – 3:05 pm – LBOR-07
A Randomized, Sham-controlled Trial of Bilateral Greater Occipital Nerve Blocks with Bupivacaine for Acute Migraine Patient’s Refractory to Standard Emergency Department Treatment with Metoclopramide
Matthew S. Robbins, MD

3:05 pm – 3:15 pm – LBOR-08
Rimegepant and BHV-3500, Small Molecule CGRP Receptor Antagonists, Exhibit No Active Vasoconstrictive Properties in Ex Vivo Human Coronary or Cerebral Arteries
Charles M. Conway, PhD

3:15 pm – 3:25 pm – LBOR-09
Neuromodulation of Cortical Spreading Depression in the Ferret
Serapio M. Baca, PhD

3:35 pm – 4:30 pm – Frontiers in Headache Research Scholarship Presentation
Central and Systemic Inflammation After Spreading Depolarizations
Tsubasa Takizawa, MD, PhD

3:45 pm – 4:30 pm – Committee and Section Meetings

4:30 pm – 5:15 pm – John R. Graham Award Lecture
Moderators: David W. Dodick, MD, FAHS and Paul Rizzoli, MD, FAHS
Teaching Headache Neurology 2018
R. Allan Purdy Md, FRCPC

SUNDAY, JULY 1, 2018

7:00 am – 8:00 am – Continental Breakfast

8:00 am – 9:30 am – PLENARY – Part 3
Chronic Migraine vs. Chronic Pain: Similarities and Differences
Moderators: Morris Levin, MD, FAHS and Paul Winner, DO, FAHS
Supported by Allergan, Inc.

8:00 am – 8:30 am – Clinical Differences/Background
David W. Dodick, MD, FAHS

8:30 am – 9:00 am – Chronic Migraine vs Chronic Pain as Seen in Imaging Studies in Humans
David Borsook, MD, PhD

9:00 am – 9:30 am – Pathophysiological Differences and Similarities as Seen in Translational Studies in Animals and Humans
Rami Burstein, PhD

9:30 am – 10:00 am – OPEN DEBATE
Questions, Answers and Comments by Participants and Presenters
Moderator: Andrew C. Charles, MD, FAHS
David Borsook, MD, PhD
Rami Burstein, PhD
David W. Dodick, MD, FAHS

Book Now
iStock-623519652

Online registration is closed. You may still register on-site.

*Please Note: The AHS member site and registration site are not linked. If you have just renewed your membership or are a new member, the registration site will not recognize your email address until Friday afternoon. Each Friday a manual upload will be done for that week’s renewals or new members.

If you would prefer to register via mail or fax, please click here for the downloadable registration form.

The following are the AHS Member and Non-Member registration categories and associated fees for the 60th Annual Scientific Meeting.

Categories and Fees On or before April 30, 2018
May 1, 2018 – June 18, 2018
On-site
AHS Member (MD, DO, PhD, DDS)Non-member (MD, DO, PhD, DDS)  $525.00

$675.00

 $575.00

$725.00

$825.00

$975.00

AHS Member Allied Health ProfessionalNon-member Allied Health Professional  $250.00

$300.00

 $300.00$350.00 $550.00

$600.00

AHS Member Residents / TraineesNon-member Residents / Trainees  $150.00$200.00  $150.00$200.00 $400.00

$400.00

Active Military Personnel $150.00 $150.00 $400.00
Industry Representative $675.00  $725.00 $975.00

Pre-Meeting Course Registration Fees

AHS Member
 Complimentary  Complimentary $250.00
Non-member  $300.00 $350.00 $600.00

Registration Information
Registration fees include: admission to all Scientific Sessions, Exhibit Hall, Continental Breakfasts, Refreshments Breaks, and Receptions.

Acceptable Forms of Payment
Checks are acceptable when registration is submitted by mail or completed onsite at the Annual Meeting. Checks must be made payable (in US dollars) to the American Headache Society and issued by a US correspondent bank. The registration is responsible for any and all bank charges.

Credit cards may be used for all registrations. AHS accepted Visa, MasterCard, and American Express. AHS reserves the right to charge the correct amount, if different from your calculated total. Charges will appear on your statement as “AHS Registration”. Note: registrations paid by credit card may be faxed to +856-432-3420. Keep a copy of your fax transmittal confirmation for your record. If faxing, do not mail the original form, doing so may result in duplicate charges to your credit card.

Wire Transfers are accepted provided that the NET AMOUNT of the wire (after bank fees) is sufficient to cover all registration fees in US dollars. Please contact AHS Registration (856-423-0043) for additional information on wire transfer payments.

Cash and Travelers Checks (US dollars only) are accepted for onsite registration at the Annual Meeting. Please do not send cash or travelers checks through the mail.

Group Discounts
AHS encourages you and your colleagues to take advantage of the discounted fees available when two or more from an organization (same location) register for the meeting. Registration for group discounts must be submitted together (by mail or fax) with acceptable form(s) of payment. A discount of $25.00 will be applied after the first registration is charged the full registration amount. The group discount is not available through online registration.

Letters of Invitation
If requested, the AHS will send a personal invitation for participation at the Annual Meeting. It should be understood that such an invitation is only to assist participants of the Annual Meeting to raise travel funds and to obtain a VISA and not a commitment on the part of the AHS to provide any financial support.

Cancellation Policy
If you must cancel your registration, all requests must be received in writing by AHS Registration, 19 Mantua Road, Mt. Royal, NJ 08061 or email: ahshq@talley.com and postmarked no later than June 15, 2018. All fees paid will be refunded minus a $100.00 processing fee. There will be no refunds after the June 15, 2018 deadline. Cancellation requests can be faxed to 856-423-0082 Attention: AHS Registration Department.

Book Now
iStock-623519652

Conference Hotel
San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103

The American Headache Society (AHS) room block at the San Francisco Marriott Marquis is SOLD OUT. A list of alternate hotels is listed below which are within close proximity to the San Francisco Marriott Marquis.

Please note, AHS does not have room blocks or agreements regarding discounted rates at the hotels listed below and cannot guarantee availability.  Additionally, please note that should you secure a reservation at any of the hotels listed below, transportation to/from the Conference Hotel, the San Francisco Marriott Marquis, is not provided by AHS and you are responsible for your own ground transportation arrangements.

Park Central San Francisco
https://www.parkcentralsf.com/
0.2 miles walking from Marriott Marquis
50 3rd Street
San Francisco, CA 94103
415-974-6400

Parc 55 San Francisco Union Square
http://www3.hilton.com/en/hotels/california/parc-55-san-francisco-a-hilton-hotel-SFOSFHH/index.html
0.3 miles walking from Marriott Marquis
55 Cyril Magnin Street
San Francisco, CA 94102
415-392-8000

The Westin St Francis Union Square
http://www.westinstfrancis.com/
0.4 miles walking from Marriott Marquis
335 Powell Street
San Francisco, CA 94102
415-397-7000

Hilton San Francisco Union Square
http://www3.hilton.com/en/hotels/california/hilton-san-francisco-union-square-SFOFHHH/index.html
0.5 miles walking from Marriott Marquis
333 O’Farrell Street
San Francisco, CA 94102
415-771-1400

Grand Hyatt San Francisco 
https://sanfrancisco.grand.hyatt.com/en/hotel/home.html
0.5 miles walking from Marriott Marquis
345 Stockton Street
San Francisco, CA 94108
415-398-1234

TRANSPORTATION

Airport
San Francisco International Airport – SFO
SFO Airport Phone: 650-821-8211
Hotel direction: 13.8 miles NW

The San Francisco Marriott Marquis does not provide shuttle service.

Ground Transportation

Taxis
Taxis depart from the designated taxi zones located at the roadway center islands, on the Arrivals/Baggage Claim Level of all terminals. Uniformed taxi coordinators are stationed at the taxi zones from 7:00 a.m. to 1:00 a.m. to assist passengers with questions or concerns.

ADA taxis are available upon request.

All major credit cards are accepted. Metered rates apply to all destinations. Destinations either 15 miles beyond the limits of the City and County of San Francisco or 15 miles beyond the boundaries of San Francisco International Airport are charged at 150% of the metered rate. A $2.00 exit surcharge is included in all San Francisco taxicab meter fares for rides originating from San Francisco International Airport. By sharing a ride, up to 5 persons can ride for the price of 1 person.

Shared Ride Van Service
Van terminal access is as follows:

  • Domestic Terminals – pick-up and drop-off on the Arrivals Level terminal center Island.
  • International Terminal – pick-up and drop-off on the Arrivals Level roadway center island.

The following Shared Ride Van Service is contracted at San Francisco International Airport:

  • SuperShuttle: 800-258-3826
  • Airport Express: 415-775-5121
  • American Airporter Shuttle: 415-202-0733
  • GO Lorries Airport Shuttle: 415-334-9000

Shared ride vans provide service between SFO and passenger-specified locations. Depending on the number of passengers, shared ride vans may make multiple stops. Please call specific provider for pricing. Passengers without prior reservations are required to check-in at the Shared Ride Van monitor located at the Arrivals Level information booth of each terminal prior to proceeding to the Shared Ride Van location.

Limousines
Advanced reservations are required for trips to/from SFO. Please contact the limousine operator directly. Limousine operators are not authorized to solicit customers at the terminal building. For-hire limousines are available on a pre-arranged basis and offer door-to-door service. Please proceed to the Courtesy Information Center located in the baggage claim area to contact the companies directly. Once a reservation is made, the company will direct you to the pre-arranged pick-up area where they will meet you.

  • Embarque San Francisco: 866-444-2144
  • Green Carpet Limousine: 925-362-0304
  • A Plus Limousine: 800-583-5466
  • Early Bird Airport Shuttle: 831-462-3933
  • LimoLux USA: (855) 307-7980
  • All Star Trans: (480) 628-3722

Rates vary according to destination. All major credit cards are accepted.

For additional information, please visit the airport website by clicking here

Car Rentals
San Francisco International Airport’s Rental Car Center allows travelers to pick up and drop off rental cars at one convenient, central location. To access the Rental Car Center from the airport terminals, take the AirTrain Blue Line. AirTrain, SFO’s fully automated people mover system, operates 24 hours every day and provides frequent service throughout SFO. AirTrain stations are located in all terminals, terminal parking garages, the Rental Car Center and SFO’s BART station. For additional information, please visit the airport website by clicking here.

Car Rentals At this property: Hertz Phone: 1-415-957-9425

Click here for rental information.

Driving Directions from San Francisco International Airport to San Francisco Marriott Marquis

  • Follow the signs for the ramp to “Hwy 101 North San Francisco.”
  • Continue on 101 North 9.2 miles to the San Francisco freeway interchange of Hwy 101 & I-280.
  • Move to the far right lane, following the sign for “North 280/Downtown S.F.”
  • Continue 10 miles and exit the freeway via the 6th Street off-ramp.
  • Proceed straight down the off-ramp onto 6th Street.
  • Drive 4 blocks to Folsom Street & turn right. Proceed 3 blocks to 3rd Street & turn left.
  • Continue 2 blocks to Mission Street and turn left.
  • The hotel’s driveway, which will be within one block on the right, is located between 3rd & 4th Streets.

Parking at the San Francisco Marriott Marquis
Valet parking Only, fee: $74.24 daily

Book Now
iStock-623519652

Welcome to the American Headache Society (AHS) 60th Annual Scientific Meeting Press Room. Here you can find the latest news releases related to this scientific forum, as well as press guidelines for media professionals, exhibitors, presenters and satellite symposia organizers. If you are a media professional looking to request a press pass for the upcoming meeting, please check out the press guidelines posted below. If you have any questions or wish to speak to a member of the AHS or the American Migraine Foundation, please reach out to Alyssa Bleiberg at alyssa.bleiberg@syneoshealth.com.

AHS Press Guidelines
Media Guidelines for Exhibitors and Presenters

Join us for a webcast highlighting the most important and groundbreaking data, hosted by Peter Goadsby, MD, PhD, FAHS, AHS Scientific Program Committee Chair, Professor of Neurology, King’s College London, neurologist and headache specialist at University of California, San Francisco, and director, NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College Hospital, London.

The presentation will begin at 12:00 p.m. EDT on Thursday, June 28, and a Q+A will follow. Please submit questions before the webcast to Lucille.bootman@syneoshealth.com.

Register for the webcast here.

 

Book Now

Latest Tweets